• Breakdown of Blood-Brain Barrier May Drive Dementia drugs
    January 16, 2019
    Breakdown of the blood-brain barrier (BBB) may be an early biomarker of cognitive dysfunction, independent of amyloid or tau marker status, according to a study published online Jan. 14 in Nature Medicine....
PharmaSources Customer Service